North America Hemostats
North America Hemostats market is immensely driven due to increasing number of insurance providers and increasing surgery procedures. The North America Hemostats report defines and segments the concerned market with analysis and forecast of revenue. The North America Hemostats market is pegged at USD 1.28 billion in 2015 and is estimated to grow to around USD 1.80 billion by 2021, at a developing CAGR of 5.8% from 2016 to 2021.

Upcoming

Hemostats
The global Hemostats market is expected to reach USD 2.9 billion by 2021 from USD 2.0 billion in 2014, at a CAGR of 6.2% from 2016 to 2021. In 2015, Americas dominated the Hemostats market registering around 62.8% market share, and the region’s market is expected to grow at a CAGR of 5.8% during the forecast period.

Asia Hernia Repair Market
It is segmented on basis of . What makes our report unique? You can request 10% customization in the research matching your exact requirement for e.g. deep dive research in any specific geography or technology or applications....

Europe Knee Reconstruction Market
It is segmented on basis of . What makes our report unique? You can request 10% customization in the research matching your exact requirement for e.g. deep dive research in any specific geography or technology or applications....

Knee Reconstruction Market
It is segmented on basis of geographies.
What makes our report unique?
You can request 10% customization in the research matching your exact requirement for e.g. deep dive research in any specific geography or technology or...

Upcoming

Asia-Pacific Prosthetic Heart Valves
The Asia Pacific prosthetic heart valve market was estimated to grow from USD 454.4 million in 2015 to USD 829.6 million in 2021, at a CAGR of 10.6%. The purpose of this report is to cover the description, definition and forecast of the Asia Pacific Prosthetic Heart Valve market. It involves deep dive analysis of market segmentation, which comprises of products and country.

Upcoming

Asia Pacific Hemostats
The Asia-pacific Hemostats market is expected to reach USD 455.9 million by 2021 from USD 290.3 million in 2015, at a CAGR of 7.8% from 2016 to 2021. In 2015, Japan dominated the Hemostats market registering around 32.6% market share, and the region’s market is expected to grow at a CAGR of 7.8% during the forecast period. Factors such as increasing surgery procedures, increasing number of insurance providers are propelling the growth of this market.

Upcoming

ECMO
The Extracorporeal Membrane Oxygenation (ECMO) System market is valued at USD 235.9 million in 2015 and is expected to reach USD 299.2 million by 2021, to grow at a CAGR of 4.0%, annually. The global Extracorporeal Membrane Oxygenation (ECMO) System market is geographically segmented into North America, Europe, Asia-Pacific and rest of the world (RoW). North America market had the largest share of about 45% of the global Extracorporeal Membrane Oxygenation (ECMO) System market, which is expected to grow at the CAGR of 3.9%.

North America Biopreservation Media
The North American biopreservation media market is estimated to grow at a CAGR of 17.6% from 2016 to 2021. The biopreservation media market in the U.S. is the largest in the world and is growing at a steady pace. Regenerative medicines, biobanking, and drug discovery are the major application areas for biopreservation media for preserving cells, tissues, and organs. Due to rapid advancements in these application areas, the demand for biopreservation media is likely to grow extensively in coming years.

Upcoming

Asia Pacific Biopreservation Media
The research report categorizes the Asia pacific biopreservation media market by product type, by application and by country. Based on product type, the market is categorized into home-brew media and pre-formulated media. Based on application, it is segmented into regenerative medicine, drug discovery and biobanking. Report covers major countries which includes Japan, China, India, Republic of Korea, and Australia.